Enlivex Therapeutics Stock (NASDAQ: ENLV) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 73.47K |
Day Range | - - - |
52 Wk Range | 1.15 - 4.59 |
Market Cap | $32.11M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 60 |
Short Interest | 0.47% |
Days to Cover | 2.49 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Enlivex Therapeutics (NASDAQ:ENLV) through any online brokerage.
There are no as such competitors for Enlivex Therapeutics.
Enlivex Therapeutics has a consensus price target of $9.50.
The stock price for Enlivex Therapeutics (NASDAQ: ENLV) is $1.4999 last updated September 23, 2024 at 6:27 PM EDT.
There are no upcoming dividends for Enlivex Therapeutics.
Enlivex Therapeutics’s Q2 earnings are confirmed for Saturday, November 30, 2024.
There is no upcoming split for Enlivex Therapeutics.
Enlivex Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.